VistaGen Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €419.22K -54.3% -€44.35M +75.1% -10,579.8% -78 pp -€36.15M +62.7% -8,622.6% -62 pp
    €917.80K -568.7% -€25.33M -50.4% -2,759.6% -290 pp -€22.21M -48.0% -2,420.3% -240 pp
    -€195.81K -120.5% -€51.11M +24.0% 26,100.4% +300 pp -€42.70M +9.9% 21,807.5% +260 pp
    €956.53K +1.8% -€41.20M +166.3% -4,307.2% -27 pp -€38.86M +281.9% -4,063.1% -30 pp
    €939.79K +∞% -€15.47M -13.7% -1,646.1% -16 pp -€10.18M -25.1% -1,082.9% -11 pp
    €0.00 +NaN% -€17.92M -15.5% N/A -€13.59M +9.8% N/A
    €0.00 +NaN% -€21.21M +71.4% N/A -€12.38M +58.5% N/A
    €0.00 -100.0% -€12.37M +39.9% N/A -€7.81M +29.0% N/A
    €1.08M +∞% -€8.85M -78.3% -820.4% -8.2 pp -€6.06M +46.9% -561.8% -5.6 pp
    €0.00 +NaN% -€40.73M +240.1% N/A -€4.13M +72.7% N/A
    €0.00 +NaN% -€11.98M +367.9% N/A -€2.39M +30.8% N/A
    €0.00 -100.0% -€2.56M -77.0% N/A -€1.83M -36.4% N/A
    €172.86K -85.1% -€11.12M +5.5% -6,430.5% -55 pp -€2.87M -5.8% -1,660.6% -14 pp
    €1.16M +∞% -€10.53M +135,923.8% -909.7% -9.1 pp -€3.05M +51,272.5% -263.3% -2.6 pp
    €0.00 +NaN% -€7.74K -59.2% N/A -€5.93K -69.8% N/A
    €0.00 +NaN% -€18.98K +34.0% N/A -€19.63K +73.0% N/A
    €0.00 +NaN% -€14.16K +245.3% N/A -€11.34K -∞% N/A
    €0.00 -€4.10K N/A €0.00 N/A

    Notifications